Bipartisan momentum on drug-patent reform could clear a faster path for affordable generics

Source: Niskanen Center
by Caitlin Rowley Gallamore & Anna Spahn

“Congressional momentum on drug patent reform, tabled at the end of the 118th Congress, is building again. Bipartisan support is coalescing behind House legislation targeting ‘patent thickets,’ which brand-name drugmakers use to keep competing, lower-cost products from entering the market. The measure, along with a related Senate bill, reflects long-overdue progress on patent reform.” (07/09/26)

https://www.niskanencenter.org/bipartisan-momentum-on-drug-patent-reform-could-clear-a-faster-path-for-affordable-generics/